The therapeutic effectiveness of 177Lu-lilotomab in B-cell non-Hodgkin lymphoma involves modulation of G2/M cell cycle arrestAlexandre Pichard, Jean‐Pierre Pouget, S Marcatili et al.|Leukemia|2019Cited by 25
Realistic multi-cellular dosimetry for<sup>177</sup>Lu-labelled antibodies: model and applicationS Marcatili, Manuel Bardiès, Jean‐Pierre Pouget et al.|Physics in Medicine and Biology|2016Cited by 21
Pharmacokinetics and biodistribution of samarium-153-labelled OC125 antibody coupled to CITCDTPA in a xenograft model of ovarian cancerFrançoise Kraeber‐Bodéré, Jean‐François Chatal, Jean Le Boterff et al.|European Journal of Nuclear Medicine and Molecular Imaging|1996Cited by 20